Progressive supranuclear palsy (PSP) is a rare neurodegenerative condition that is a form of atypical parkinsonism, meaning that it shares some features with Parkinson's disease. These include ...

Arvinas, Inc. (NASDAQ:ARVN) unveiled first-in-human data on Friday for its experimental Parkinson’s disease treatment, ARV-102. Results from the randomized, double-blind, placebo-controlled single ...

Virginia Rep. Jennifer Wexton opens up to PEOPLE about her diagnosis of progressive supranuclear palsy — or "Parkinson's on steroids" — a rare and degenerative disorder that's forcing her into ...

Patients with PSP often have the “procerus sign” which is a particularly “worried” facial expression. The second most common form of atypical parkinsonism is multiple system atrophy (MSA – a ...

Disease severity was measured using PSP Rating Scale for PSP participants (0 = no symptoms – 100) and Unified Parkinson's disease Rating Scale – motor subsection (UPDRS III) for PD ...

"This study is a game-changer for using a common MRI scan to differentiate Parkinson's disease, multiple system atrophy and PSP," Okun told MedPage Today. "The method was tested on a 21-center NIH ...

Clinical practices and diagnostic challenges increase misdiagnoses Commonly revised diagnoses included vascular parkinsonism, progressive supranuclear palsy, multiple system atrophy, and ...

A new study by the University of Turku and Turku University Hospital, Finland, found that a significant proportion of Parkinson's disease diagnoses are later corrected. Up to one in six diagnoses ...

While LRRK2 is primarily known for its role in Parkinson’s, Arvinas noted that emerging evidence suggests it also plays a role in tauopathies, including progressive supranuclear palsy (PSP).